Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Farmer

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
PDA Journal of Pharmaceutical Science and Technology|August 21, 2020
A Bayesian Statistical Approach to Continuous Qualification of a BioassaySteven J Novick, Elizabeth Christian, Erika Farmer, et al.
Lupus Science & Medicine|April 13, 2018
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosusJeffrey M Riggs, Richard N Hanna, Bhargavi Rajan, et al.
Mabs|December 8, 2022
Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodiesAndrew Dippel, Austin Gallegos, Vineela Aleti, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
PDA Journal of Pharmaceutical Science and Technology|August 21, 2020
A Bayesian Statistical Approach to Continuous Qualification of a BioassaySteven J Novick, Elizabeth Christian, Erika Farmer, et al.
Lupus Science & Medicine|April 13, 2018
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosusJeffrey M Riggs, Richard N Hanna, Bhargavi Rajan, et al.
Mabs|December 8, 2022
Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodiesAndrew Dippel, Austin Gallegos, Vineela Aleti, et al.
Pageof 1